Structural studies on KijD1, a sugar C-3'-methyltransferase

Area of Science:

• Biochemistry
• Structural Biology
• Enzymology

Background:

• Kijanimicin is an antitumor antibiotic produced by Actinomadura kijaniata.
• The d-kijanose moiety of kijanimicin is a unique nitro-containing tetradeoxysugar requiring multiple enzymes for biosynthesis.
• KijD1 is identified as a crucial C-3'-methyltransferase in the d-kijanose biosynthetic pathway.

Purpose of the Study:

• To elucidate the structural and quaternary characteristics of the KijD1 enzyme.
• To investigate the enzymatic mechanism of KijD1 as a C-3'-methyltransferase.
• To compare the quaternary structure of KijD1 with other sugar methyltransferases and explore structural plasticity.

Main Methods:

• X-ray crystallography was employed to determine the structures of two ternary complexes of KijD1.
• Biochemical analyses and site-directed mutagenesis were utilized to study KijD1's quaternary structure and function.
• Enzyme activity assays were performed to confirm the methyltransferase activity of KijD1.

Main Results:

• The crystal structures of KijD1 in complex with S-adenosylhomocysteine (SAH) and dTDP, or SAH and a dTDP-sugar derivative, were solved to high resolution (1.7 and 1.6 Å).
• Biochemical analyses unexpectedly revealed that KijD1 exists as a dimer, contrary to expectations based on related enzymes.
• Site-directed mutagenesis successfully converted the dimeric KijD1 into a monomeric form, demonstrating structural adaptability.

Conclusions:

• The dimeric quaternary structure of KijD1 is a novel finding for sugar C-3'-methyltransferases.
• Experimental structural determination is essential, as bioinformatics approaches alone were insufficient to predict KijD1's dimeric nature.
• This study underscores the importance of experimental validation in understanding enzyme structure-function relationships and biosynthetic pathways.